Dear Sajha members,
I have just recently started to buy and sell stock, I am doing more research on my own but if any of you have been doing investment for a period of a time and know how to do the research and investment I would like to learn from you or if you can tell me how to look at the trend and when or which to sell or buy.

Thank you,

I485,

i want to invest about ten thousand in stocks, and do not know where to start. would you be able to help man ? tell us where to spend that amount. its small but its a start, i guess.

CBIO up +200% - Hope you'll made money on this huge call .
I currently own CBIO (Catalyst Bioscience ) - - Not for long term investment but i am looking for short term pop - swing trade. It's a very thinly traded stock, so one has to be careful. 

Total O/S: only ~ 1M , Float is tiny.

I bought it at $6.35 last week , let's see how it does. "

This is awsome! But how you guys select biotech stocks? which website do you use to find?

Make some cash and enjoy some weed at the same time.

"TORONTO — Publicly traded medical marijuana companies got a bounce Monday after news reports provided clarity on the federal government’s plan for marijuana, suggesting it will be legal for pot smokers in time to celebrate Canada Day next year.

Ottawa plans to introduce marijuana legalization legislation in mid-April, fulfilling the Liberals’ promise to do so this spring. That will be enough time to enact legalization by Canada Day 2018, CBC reported Sunday night."

http://business.financialpost.com/investing/marijuana-stocks-are-smokin-today-on-report-canadas-legalization-bill-is-in-the-works

https://www.youtube.com/watch?v=qcDjpyXnjJM

I485,
Would you mind sharing your portfolio and watchlist, entry point and PT for them? Both short and long term. If not all, your top 5 would be great.

yea man please do

Kalikopoi,

CBIO was my speculative risky play posted here with Entry at $6.35 went to $20 in about two weeks.

ADAP is another one i've posted here and i am long on this one from around ~$4.30 ( i trade in and out of this as well has hold a core position ).

This is not any investment advice nor any recommendation to buy/sell any stocks. Whatever i've posted here are my opinions only.

Good luck

My ADAP doing well for me!


ADAP:
4.94+0.35 (+7.63%)
As of 2:06PM EDT. Market open.

So you made 18k just trading CBIO and ADAP?
What are your next targets?
Do you see any breakout potential on ISR, AGEN, IBIO, ACRX (I am holding these for a while) and PTX (sold yesterday before the fall started for 15% gain. Looking for reentry)?

CBIO -30% down to $10 today...

Kancho_ojha
CBIO went from $6 to $20 in a day, I sold all . I was looking for a short term pop and I had said it's not a long term investment . One must be fool not selling when stock goes from $6 to $20 .

CBIO will most likely raise a cash now , they need cash, so it'll go further down eventually . You've to understand these games in biotech.

I started position few weeks ago cuz they had a reverse split , float was very tiny after the split and that was a hot theme in the market . That is, low float reverse split stocks were going nuts ! You've to understand all that and what traders are looking for. That was the reason CBIO went crazy because total shares were about 1M only and it had some kind of news. I've seen many companies share price goes up right before dilution as well. So, I will not be surprised to see offering coming in CBIO any day ,
Imo

@485 - very impressive analysis. Can you share more tips on how you select the stock for short tern gains besides reverse splits and short sell ? Do you looks for fundamental stuffs or just technical analysis (what's going on in traders' mind :) ) ?

ADAP
5.09
+0.16 (3.25%) 2:58 PM EDT

Well my ADAP keeps going up :) cash machine $$$$$

Ok Ok. We got it.

Still no answers for my previous questions.

Kalikopoi,
Not that I am trying to ignore question . I get all the bs when I post something and it doesn't work. Some people who are new to the game may buy it without doing research and if it doesn't work they come here and blame. I've seen it many times , that's why I am hesitant to just put out lot lot of watchlist .

I will only post very few ideas for education purposes only . Hope people do their own research before putting their hard earned money. It's not easy as it looks.

By the way
ADAP
5.24
+0.31 (6.19%) 3:37 PM EDT

You can get into the following stocks if you like low float stocks. They should fly anytime soon.

NVIV
AXSM
ONCS
NEOS

Axsome (AXSM)

Market-Cap: $83 Million
Cash: $50.6 Million
Price:$3.60

Shares Out: 23 Million


Anticipated Near-Term Clinical Milestones

Clinical Trial Initiations: -- Phase 2/3 clinical trial of AXS-05 in AD agitation (2Q 2017)

Clinical Trial Readouts:

-- Phase 3 COAST-1 trial of AXS-02 in knee OA associated with BMLs, interim analysis (3Q 2017)

-- Phase 3 CREATE-1 trial of AXS-02 in CRPS, interim efficacy analysis (4Q 2017)

-- Phase 3 STRIDE-1 trial of AXS-05 in TRD, top-line data (1Q 2018)


New Presentation
media.corporate-ir.net/media_files/IROL/25/254022/Axsome_Presentation_14_Mar_2017.pdf

Major Shareholders

Herriott Tabuteau, MD 7 351 729 38,4%
Fidelity Management & Research Co. 2 361 625 12,3%
JPMorgan Asset Management (UK) Ltd. 1 432 456 7,48%
Mark Coleman, MD 647 998 3,38%
BlackRock Fund Advisors 426 837 2,23%
Stifel Trust Co., NA 415 279 2,17%
The Vanguard Group, Inc. 272 189 1,42%
Lombard Odier Asset Management (USA) Corp. 250 000 1,31%
JPMorgan Investment Management, Inc. 156 625 0,82%
SSgA Funds Management, Inc. 134 688 0,70%

HOT FDA Play

NEOS (MC $91 M) $60 M Cash / 1 Drug approved /2 Drugs awaiting FDA approval (2Q & 4Q) targeting Billion Dollar Markets .

Very attractive and unknown low float FDA play with HUGE upside Potential i see the fair value around $20 per share .GL

NEOS Therapeutics (NEOS)

Market Cap: $164.69 M
Cash: $60 M
Price $7.30

Shares Out: 16.06 M

Presentation
investors.neostx.com/phoenix.zhtml?c=254075&p=irol-presentations

•Adzenys XR-ODT launched May, 2016
•Robust preskription growth since launch
•22,797 total TRx through December 2, 2016

•Pipeline includes two late-stage product candidates for the treatment of ADHD

•Amphetamine XR-Oral Suspension —NDA Submitted Nov 15, 2016

•Cotempla (methylphenidate) XR-ODT —NDA resubmitted Dec 20, 2016